Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 1;34(2):206-212.
doi: 10.1097/WCO.0000000000000901.

Serotonergic therapy in epilepsy

Frank G Gilliam  1 , Hrvoje Hecimovic  2 , Matthew S Gentry  3
Affiliations
Review

Serotonergic therapy in epilepsy

Frank G Gilliam et al. Curr Opin Neurol. .

Abstract

Purpose of review: The serotonergic system is implicated in multiple aspects of epilepsy, including seizure susceptibility, sudden unexpected death in epilepsy (SUDEP), and comorbid depression. Despite the complexity of serotonin's effects on various neuronal networks, ongoing research provides considerable insight into the role of serotonin in human epilepsy. This review explores the potential roles of serotonergic therapies to improve clinical outcomes in epilepsy.

Recent findings: In recent decades, research has markedly increased our knowledge of the diverse effects of serotonin on brain function. Animal models of epilepsy have identified the influence of serotonin on seizure threshold in specific brain regions, serotoninergic augmentation's protective effects on terminal apnea and mortality in SUDEP, and mechanisms underlying behavioral improvement in some models of comorbid depression. Human clinical studies are largely consistent with animal data but the translation into definitive treatment decisions has moved less rapidly.

Summary: Evidence for serotonergic therapy is promising for improvement in seizure control and prevention of SUDEP. For some epilepsies, such as Dravet syndrome, basic research on serotonin receptor agonists has translated into a positive clinical trial for fenfluramine. The cumulative results of safety and efficacy studies support the routine use of SSRIs for comorbid depression in epilepsy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None

Figures

Figure 1.
Figure 1.
Results of PumMed.gov Search for Serotonin and Epilepsy.
Figure 2.
Figure 2.
Schematic of brain injury, epilepsy, associated disorders and subsequent altered serotonin transmission resulting in depression, worsened seizures, and possibly SUDEP.
See this image and copyright information in PMC

References

    1. Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 1952;169(4306):800–1. - PubMed
    1. Whitaker-Azmitia PM. The discovery of serotonin and its role in neuroscience. Neuropsychopharmacology. 1999;21(2 Suppl):2S–8S. - PubMed
    1. Twarog BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol. 1953;175(1):157–61. - PubMed
    1. Page IH. Serotonin. Chicago, IL: Yearbook Medical Publishers, Inc; 1968.
    1. Richerson GB, Buchanan GF. The serotonin axis: Shared mechanisms in seizures, depression, and SUDEP. Epilepsia. 2011;52Suppl 1:28–38. - PMC - PubMed

Publication types